Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 13/20 | 0.48 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.47 |
| ▸ | FEN1 | P39748 | 3/20 | 0.47 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30624444 | 1.00 | GPR119 (0.48) | GPR119ALOX5APFEN1SLC2A1CYP2C9 | |
| SCHEMBL30624268 | 0.94 | ALOX5AP (0.49) | GPR119ALOX5APFEN1CYP2C9 | |
| SCHEMBL30045411 | 0.86 | GPR119 (0.49) | GPR119ALOX5APFEN1SLC2A1CYP2C9 | |
| SCHEMBL23579456 | 0.86 | GPR119 (0.49) | GPR119ALOX5APFEN1SLC2A1CYP2C9 | |
| SCHEMBL29058721 | 0.86 | ALOX5AP (0.51) | GPR119ALOX5APFEN1SLC2A1CYP2C9 | |
| SCHEMBL26601448 | 0.85 | RBP4 (0.42) | CYP2C9 | |
| SCHEMBL30624264 | 0.84 | GPR119 (0.58) | GPR119ALOX5APFEN1 | |
| SCHEMBL22597591 | 0.83 | GPR119 (0.49) | GPR119 | |
| SCHEMBL22597533 | 0.83 | GPR119 (0.49) | GPR119 | |
| SCHEMBL29483711 | 0.83 | GPR119 (0.49) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4511376-A2 | EGFR INHIBITORS IN CANCER TREATMENT | Celyn Therapeutics, Inc. (US) | 2025-02-26 | — | — | EP | disclosed |
| WO-2023205595-A2 | EGFR INHIBITORS IN CANCER TREATMENT | CELYN THERAPEUTICS, INC (US) | 2023-10-26 | — | — | WO | disclosed |